-
公开(公告)号:US11950578B2
公开(公告)日:2024-04-09
申请号:US17129708
申请日:2020-12-21
发明人: Lynn Macdonald , Sean Stevens , Andrew J. Murphy , Margaret Karow
IPC分类号: C07K16/00 , A01K67/0275 , A01K67/0278 , B60H1/32 , C07K16/22 , C07K16/28 , C07K16/40 , C07K16/46 , C12N9/64 , C12N15/85
CPC分类号: A01K67/0278 , A01K67/0275 , B60H1/32281 , C07K16/22 , C07K16/28 , C07K16/2866 , C07K16/40 , C07K16/461 , C07K16/462 , C12N9/6489 , C12N15/8509 , A01K2207/15 , A01K2217/072 , A01K2217/15 , A01K2227/105 , A01K2267/01 , C07K2317/21 , C07K2317/92 , C12N2800/204 , C12N2800/30
摘要: Mice are provided that comprise a reduction or deletion of ADAM6 activity from an endogenous ADAM6 locus, or that lack an endogenous locus encoding a mouse ADAM6 protein, wherein the mice comprise a sequence encoding an ADAM6 or ortholog or homolog or fragment thereof that is functional in a male mouse. In one embodiment, the sequence is an ectopic ADAM6 sequence or a sequence that confers upon a male mouse the ability to generate offspring by mating. Mice and cells with genetically modified immunoglobulin heavy chain loci that comprise an ectopic nucleotide sequence encoding a mouse ADAM6 or functional fragment or homolog or ortholog thereof are also provided.
-
公开(公告)号:US11666040B2
公开(公告)日:2023-06-06
申请号:US16849782
申请日:2020-04-15
IPC分类号: A01K67/027 , C12P21/02 , C07K16/46
CPC分类号: A01K67/0278 , A01K67/0276 , C07K16/461 , C12P21/02 , A01K2207/15 , A01K2217/072 , A01K2217/075 , A01K2217/15 , A01K2227/105
摘要: Mice, embryos, cells, and tissues having a restricted immunoglobulin heavy chain locus and an ectopic sequence encoding one or more ADAM6 proteins are provided. In various embodiments, mice are described that have humanized endogenous immunoglobulin heavy chain loci and are capable of expressing an ADAM6 protein or ortholog or homolog or functional fragment thereof that is functional in a male mouse. Mice, embryos, cells, and tissues having an immunoglobulin heavy chain locus characterized by a single human VH gene segment, a plurality of human DH gene segments and a plurality of human JH gene segments and capable expressing an ADAM6 protein or ortholog or homolog or functional fragment thereof are also provided.
-
公开(公告)号:US20230094591A1
公开(公告)日:2023-03-30
申请号:US17749728
申请日:2022-05-20
发明人: Sean Stevens , Tammy T. Huang , Joel H. Martin , Jeanette L. Fairhurst , Ashique Rafique , Eric Smith , Kevin J. Pobursky , Nicholas J. Papadopoulos , James P. Fandl , Gang Chen , Margaret Karow
摘要: A human antibody or an antigen-binding fragment which binds human IL-6 receptor (hIL-6R) with a KD of about 500 pM or less and blocks IL-6 activity with an IC50 of 200 pM or less, is provided. In preferred embodiments, the antibody the antibody or antigen-binding fragment binds hIL-6R with an affinity at least 2-fold higher relative to its binding monkey IL-6R.
-
公开(公告)号:US20220394959A1
公开(公告)日:2022-12-15
申请号:US17734392
申请日:2022-05-02
IPC分类号: A01K67/027 , C07K16/00 , C12N9/64 , C12N15/85
摘要: Mice, tissues, cells, and genetic material are provided that comprise a humanized heavy chain immunoglobulin locus, a humanized light chain locus that expresses a universal light chain, and a gene encoding an ADAM6 or ortholog or homolog or functional fragment thereof. Mice are provided that express humanized heavy chains comprising human variable domains, and that express humanized light chains comprising human variable domains wherein the light chains are derived from no more than one, or no more than two, light chain V and J or rearranged V/J sequences. Fertile male mice that express antibodies with universal light chains and humanized heavy chains are provided. Methods and compositions for making bispecific binding proteins are provided.
-
公开(公告)号:US20200281175A1
公开(公告)日:2020-09-10
申请号:US16849782
申请日:2020-04-15
IPC分类号: A01K67/027 , C12P21/02 , C07K16/46
摘要: Mice, embryos, cells, and tissues having a restricted immunoglobulin heavy chain locus and an ectopic sequence encoding one or more ADAM6 proteins are provided. In various embodiments, mice are described that have humanized endogenous immunoglobulin heavy chain loci and are capable of expressing an ADAM6 protein or ortholog or homolog or functional fragment thereof that is functional in a male mouse. Mice, embryos, cells, and tissues having an immunoglobulin heavy chain locus characterized by a single human VH gene segment, a plurality of human DH gene segments and a plurality of human JH gene segments and capable expressing an ADAM6 protein or ortholog or homolog or functional fragment thereof are also provided.
-
公开(公告)号:US10577430B2
公开(公告)日:2020-03-03
申请号:US16059871
申请日:2018-08-09
发明人: Lynn Macdonald , Sean Stevens , Andrew J. Murphy , Margaret Karow
IPC分类号: C12N5/10 , C07K16/40 , C07K16/28 , C07K16/46 , C12N9/64 , C12N15/85 , B60H1/32 , A01K67/027 , C07K16/22
摘要: Mice are provided that comprise a reduction or deletion of ADAM6 activity from an endogenous ADAM6 locus, or that lack an endogenous locus encoding a mouse ADAM6 protein, wherein the mice comprise a sequence encoding an ADAM6 or ortholog or homolog or fragment thereof that is functional in a male mouse. In one embodiment, the sequence is an ectopic ADAM6 sequence or a sequence that confers upon a male mouse the ability to generate offspring by mating. Mice and cells with genetically modified immunoglobulin heavy chain loci that comprise an ectopic nucleotide sequence encoding a mouse ADAM6 or functional fragment or homolog or ortholog thereof are also provided.
-
公开(公告)号:US20190256606A1
公开(公告)日:2019-08-22
申请号:US16119695
申请日:2018-08-31
发明人: Sean Stevens , Tammy T. Huang , Joel H. Martin , Jeanette L. Fairhurst , Ashique Rafique , Eric Smith , Kevin J. Pobursky , Nicholas J. Papadopoulos , James P. Fandl , Gang Chen , Margaret Karow
IPC分类号: C07K16/28
摘要: A human antibody or an antigen-binding fragment which binds human IL-6 receptor (hIL-6R) with a KD of about 500 pM or less and blocks IL-6 activity with an IC50 of 200 pM or less, is provided. In preferred embodiments, the antibody the antibody or antigen-binding fragment binds hIL-6R with an affinity at least 2-fold higher relative to its binding monkey IL-6R.
-
公开(公告)号:US10227625B2
公开(公告)日:2019-03-12
申请号:US13719842
申请日:2012-12-19
发明人: Andrew J. Murphy , George D. Yancopoulos , Margaret Karow , Lynn Macdonald , Sean Stevens , Aris N. Economides , David M. Valenzuela
IPC分类号: C12P21/00 , A01K67/027 , C07K16/00 , C12N15/90 , C12N15/67 , C07K16/46 , C12N15/85 , C07K16/28
摘要: A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous gene(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.
-
公开(公告)号:US09308256B2
公开(公告)日:2016-04-12
申请号:US14020573
申请日:2013-09-06
发明人: Allen Radin , Sean Stevens , Tammy T. Huang , Joel H. Martin , Jeanette L. Fairhurst , Ashique Rafique , Eric Smith , Kevin J. Pobursky , Nicholas J. Papadopoulos , James P. Fandl , Gang Chen , Margaret Karow
IPC分类号: A61K39/395 , A61K31/4706 , A61K31/519 , A61K31/655 , A61K38/19 , A61K45/06 , C07K16/28 , C07K16/24 , A61K39/00
CPC分类号: A61K39/3955 , A61K31/4706 , A61K31/519 , A61K31/655 , A61K38/191 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/248 , C07K16/2866 , C07K2317/21 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , Y10S514/885 , A61K2300/00
摘要: The present invention provides methods of preventing or treating rheumatoid arthritis using a fully human antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R). The methods of the present invention may include administration of a second therapeutic agent, such as one or more of a non-steroidal anti-inflammatory drug (NSAID), a glucocorticoid, a disease-modifying anti-rheumatic drug (DMARD), or a TNF-alpha antagonist, T-cell blocker, anti-CD20 antibody, an IL-1, JAK or IL-17 antagonist, or any combination thereof.
-
公开(公告)号:US08895801B2
公开(公告)日:2014-11-25
申请号:US14036514
申请日:2013-09-25
发明人: Andrew J. Murphy , George D. Yancopoulos , Margaret Karow , Lynn Macdonald , Sean Stevens , Aris N. Economides , David M. Valenzuela
IPC分类号: C12P21/00 , A01K67/00 , A01K67/027 , C07K16/00 , C12N15/90 , C12N15/67 , C07K16/46 , C12N15/85 , C07K16/28
摘要: A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous gene(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.
-
-
-
-
-
-
-
-
-